ALS Learning Series
Evidence-Based Consensus Guidelines for Genetic Counseling and Testing in ALS
May 11, 2023
![Image](https://931124.p3cdn2.secureserver.net/wp-content/uploads/2023/05/Roggenbuck.headshot.10.19.jpg?time=1722016283)
Jennifer Roggenbuck, MS, CGC
The practice of genetic testing in ALS has been impacted by high patient demand for testing, sponsored testing programs, and a new drug application to the FDA for the first gene-targeted therapy in ALS. However, many challenges exist, including few genetic counselors in ALS clinics, and issues with laboratory methods and reporting. Jennifer Roggenbuck, MS, CGC will present new evidence-based, consensus guidelines for genetic counseling and testing in ALS, a project sponsored by the ALS Association.
Jennifer Roggenbuck is a genetic counselor and Associate Professor at the Ohio State University, where she studies genetic testing and counseling outcomes and best practices in ALS clinical genetics.
![ALS Learning Series](https://931124.p3cdn2.secureserver.net/wp-content/uploads/2022/09/als-learning-series-resources.png?time=1722016283)
ALS Learning Series Sponsors
The ALS Learning Series is made possible by a generous donation from the Gilbert and Jacqueline Fern Foundation and our industry partners.
![Image](https://931124.p3cdn2.secureserver.net/wp-content/uploads/2021/03/MT_Logo_Stacked-_Final_4C-002-e1616506883510.png?time=1722016283)
![](https://931124.p3cdn2.secureserver.net/wp-content/uploads/2016/02/als-white.png?time=1722016283)